RELATED CONTENT
NEWS
- NICE no for Tyverb and Herceptin in breast cancer, Roche considers appeal
- Patchy reimbursement and HTAs leave smoking cessation drugs short of breath
- BMS' Sprycel loses out to Novartis' discounted Tasigna in England
- Patient access scheme prompts NICE U-turn on Novartis' Tasigna, while BMS will appeal against no for Sprycel
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here


